The researchers said that the intention behind the development of the device was to provide access to lab-quality diagnosis and results in remote places of the planet at a fraction of the cost. Though the device itself will cost in region of hundreds of dollars, it will be provided for free in developing countries while the cost of a single cartridge will be $17.
"Recent research suggests there's a real danger that artemisinins could eventually become obsolete, in the same way as other anti-malarials. New drug treatments take many years to develop, so the quickest and cheapest alternative is to optimize the use of current drugs. The huge advances in tech are now giving us a tremendous opportunity to do that and to avoid people falling seriously ill", NanoMal project lead Sanjeev Krishna said.
Source: Medindia
